Stockreport

Galectin Therapeutics Inc. (GALT) Surges on Promising Belapectin Trial Data and Strong Financials [Yahoo! Finance]

Galectin Therapeutics Inc.  (GALT) 
Last galectin therapeutics inc. earnings: 11/12 08:00 am Check Earnings Report
PDF Galectin Therapeutics Inc. (NASDAQ:GALT) is a biopharmaceutical company developing therapies targeting galectin proteins, with its lead candidate, belapectin, focused o [Read more]